EHJJClub
Cortisol in cardio-kidney-metabolic disease.
European Heart Journal · · Journal Article
Khan, Arshad + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Hypercortisolism is linked to worse cardio-kidney-metabolic outcomes, with MACS associated with a 2.5-fold higher risk of cardiovascular death and higher rates of hypertension, T2DM, and kidney impairment.
- Why it matters: Many CKM patients stay uncontrolled despite guideline-directed therapy, partly because secondary causes like cortisol excess are underrecognized and not routinely addressed.
- What they did: The review synthesizes evidence that the overnight 1 mg dexamethasone suppression test is the diagnostic test of choice, and cites prospective CKM cohorts showing 24% prevalence in difficult-to-control T2DM (CATALYST) and 27% in resistant hypertension (MOMENTUM).
- The result: It supports integrating cortisol-targeted evaluation and therapies—such as steroidogenesis inhibitors, glucocorticoid receptor antagonists, and selected pituitary-directed treatments—into management pathways, while calling for trials and standardized diagnostic thresholds.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.